A scoping review of high-flow nasal cannula therapy in advanced cancer: implications for quality of life, psychological well-being, and family-centered decision-making

Résumé fourni par la source

High-flow nasal cannula (HFNC) oxygen therapy has received increasing attention as a noninvasive respiratory support modality for patients with advanced cancer. This scoping review examines the clinical application of HFNC in advanced cancer complicated by respiratory failure, with a focus on its potential contributions to symptom relief, quality of life (QoL), psychological well-being, and family-centered decision-making. By synthesizing current clinical evidence, this scoping review suggests that HFNC may reduce dyspnea while helping preserve patients’ ability to communicate and maintain oral intake during the terminal phase, thereby supporting overall QoL. Compared with other respiratory support modalities, such as noninvasive ventilation (NIV), HFNC may offer advantages in tolerability, comfort, and psychological acceptability. However, challenges remain, including ethical dilemmas, resource allocation, and decisions regarding treatment withdrawal. Overall, HFNC may have a supportive role in end-of-life care and advance care planning by supporting patient autonomy and shared decision-making among patients, families, and healthcare professionals.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.